RSK inhibitor BI-D1870, Purity ≥98%

Cat. No.: X24-05-ZQ237

RSK inhibitor BI-D1870, Purity ≥98%

Synonym: 501437-28-1; BI-D1870; 2-((3,5-Difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one; BI-D 1870; 2-(3,5-Difluoro-4-hydroxyanilino)-5,7-dimethyl-8-(3-methylbutyl)-7H-pteridin-6-one; RSK inhibitor

  • CAS Number: 501437-28-1
  • Compound CID: 25023738
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
BI-D1870, soluble in DMSO and insoluble in ethanol and water, attenuates the activity of kinases involved in cell growth, survival, and proliferation, which can be utilized to inhibit tumor progression. It targets RSK1, RSK2, RSK3, and RSK4.
Molecular Weight
391.41
Molecular Formula
C19H23F2N5O2
Targets
RSK1; RSK2; RSK3; RSK4
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 71 mg/mL (181.39 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
BI-D1870 can be employed to study its effects on RSK kinase activity and downstream signaling events in cancer.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.